Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics. It utilizes its Endosomal Escape Vehicles (EEV) technology to create a pipeline of enzyme, oligonucleotide, protein, and peptide programs enabling intracellular delivery of therapeutics into a variety of organs and tissues. The company focuses on the treatment of neuromuscular disease, immunology, oncology, and diseases of the central nervous system.